ArticleJournal of translational medicine2012

Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3.

Lei Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.